Your session is about to expire
← Back to Search
Lifestyle Intervention for Cancer Survivors (Small Steps Trial)
Small Steps Trial Summary
This trial looks at whether a 10-week program of exercise and healthy eating can help cancer survivors improve their fitness and lose weight.
Small Steps Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSmall Steps Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Small Steps Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have finished my main cancer treatments but may still be on hormone or targeted therapy.I have had cancer before.I am currently using weight loss medications or devices.I currently have no signs of cancer returning or remaining.I agree to let my samples and data be stored for future research.I had weight loss surgery in the past year.I do not have heart, lung, or muscle conditions that prevent me from exercising.I have lost more than 11 kg on purpose in the last 3 months.I am 18 years old or older.My BMI is 30 or higher, or it's 27 or higher with weight-related health issues.
- Group 1: Multimodal Lifestyle Program
- Group 2: Waitlist Control
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the scope of this medical trial's participants?
"Affirmative, the information on clinicaltrials.gov verifies that this trial is open for recruitment. The study was initially posted on August 19th 2021 and most recently updated on February 7th 2022. It seeks 54 individuals from a single site."
What aims is this trial attempting to accomplish?
"During the Baseline and Week 10 period, researchers will primarily evaluate a Change in body weight as co-primary outcome. Other secondary outcomes to be monitored include Changes in systolic blood pressure (taken after 5 minutes of rest), fat Mass measured with dual energy x-ray absorptiometry, and physical/mental quality-of life assessed by administering SF-36 surveys."
Are there still vacancies available for participation in this trial?
"Per the information hosted on clinicaltrials.gov, this medical research is currently seeking participants. The trial was initially listed on August 19th 2021 and revised most recently on February 7th 2022."
Share this study with friends
Copy Link
Messenger